General Information of the Compound
Compound ID
CP0463107
Compound Name
2-[4-(3,4-dihydro-2H-chromen-2-ylmethylamino)butyl]-1,1-dioxo-1,2-benzothiazol-3-one
    Show/Hide
Structure
Formula
C21H24N2O4S
Molecular Weight
400.5
Canonical SMILES
O=C1N(CCCCNCC2CCc3ccccc3O2)S(=O)(=O)c2ccccc12
    Show/Hide
InChI
InChI=1S/C21H24N2O4S/c24-21-18-8-2-4-10-20(18)28(25,26)23(21)14-6-5-13-22-15-17-12-11-16-7-1-3-9-19(16)27-17/h1-4,7-10,17,22H,5-6,11-15H2
    Show/Hide
InChIKey
YGYBFMRFXNDIPO-UHFFFAOYSA-N
Physicochemical Property
logP
2.5947
Rotatable Bonds
7
Heavy Atom Count
28
Polar Areas
75.71
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9822317
SID: 14781305
ChEMBL ID
CHEMBL1926761
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 1.5 nM
   TI
   LI
   LO
   TS